On July 2, Commission Implementing Regulation (EU) 2026/1306 of 11 June, 2026, authorizing the placing on the market of rhamnogalacturonan-I enriched carrot extract (cRG-I) as a novel food and amending Implementing Regulation (EU) 2017/2470, entered into force.
The novel food product consists of a carrot pulp extract selectively enriched with rhamnogalacturonan-I domains through an enzymatic process (selectively degrading the pectin portion), followed by enzyme inactivation, further purification, heat treatment, drying, and pasteurization.
It is authorized for use in various food categories, including food supplements, and the designation on the labeling of foods containing it must be rhamnogalacturonan-I carrot extract.
For food supplements, the maximum permitted content shall be 1,500 mg / day, and the following warning must appear on the label: must not be consumed by children under 3 years of age.
Only the company NutriLeads B.V. is authorised to place the novel food on the market within the Union for a period of five years from 2 July 2026, unless a subsequent applicant obtains authorisation for that novel food without reference to the protected scientific data or with the agreement of NutriLeads B.V.